The current status of CLL treatment and how clinical practice will change
Myeloma 2016: Panel discussion on the status of genomics
Chng Wee Joo et al.
Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients
Venetoclax and ibrutinib and drug combinations for CLL
What is the role for idelalisib and duvelisib in CLL?